MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction) (MYTHS-MR)
Single-blind, Investigator-initiated, Randomized, Controlled Trial to Assess the Safety and Efficacy of Intravenous Corticosteroid Therapy to Treat Patients With Acute Myocarditis With Mildly Reduced Left Ventricular Ejection Fraction
Sponsor: Niguarda Hospital
A PHASE3 clinical study on Acute Myocarditis, this trial is actively recruiting participants. The trial is conducted by Niguarda Hospital and has accumulated 8 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
May 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — May 2025 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
-
Oct 2023 — Dec 2023 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2023 — Oct 2023 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Niguarda Hospital
- University Hospital, Antwerp
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Aalst, Belgium , Antwerp, Belgium , Arezzo, Italy , Bergamo, Italy , Brescia, Italy , Edegem, Belgium , Florence, Italy , Hasselt, Belgium , Lecco, Italy and 7 more locations